In one paragraphSynthesis in Journal of child neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Rima El AtracheDepartment of Pediatrics, Division of Neurology and Developmental Neurosciences, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.ORCID 0000-0002-5600-1120 Melissa MizerikDepartment of Pediatrics, Division of Neurology and Developmental Neurosciences, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.
Joaquin Francisco Ruiz LopezDepartment of Neuroradiology, Baylor College of Medicine, Houston, TX, USA.
Eric EngstromDepartment of Pediatrics, Division of Infectious Diseases, Baylor College of Medicine, Houston, TX, USA.ORCID 0009-0002-6494-6842 Karla Patricia SalazarDepartment of Pediatrics, Division of Neurology and Developmental Neurosciences, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.
Mikael C Guzman-KarlssonDepartment of Pediatrics, Division of Neurology and Developmental Neurosciences, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.ORCID 0000-0002-0183-2277 Daniel Davila-WilliamsDepartment of Pediatrics, Division of Neurology and Developmental Neurosciences, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.
Sonali SenDepartment of Pediatrics, Division of Neurology and Developmental Neurosciences, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.
Kristen S FisherDepartment of Pediatrics, Division of Neurology and Developmental Neurosciences, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.ORCID 0000-0002-1598-8571 Jennifer C ErklauerDepartment of Pediatrics, Division of Neurology and Developmental Neurosciences, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Mucormycosis is a rare, life-threatening opportunistic infection primarily affecting immunocompromised patients. The available literature on
Indexed as
Central Nervous System Fungal InfectionsMucormycosisRhizomucorStrokeAdolescentHumansImmunocompromised HostCNS infectionsIsolated intracranial mucormycosisRhizomucor pusillus
Identifiers
PMID40329649
PMCPMC12332211
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390